COMMUNIQUÉS West-GlobeNewswire

Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
02/04/2026
CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, has been awarded a ten-year contract valued at [...]
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
02/04/2026
MediWound Reports BARDA Contract Award to Vericel for NexoBrid ® Valued at up to $197 Million YAVNE, Israel, April 2, 2026 — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics [...]
Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month
02/04/2026
LivMedCell’s Ministry of Health-licensed cGMP framework supports physician-led evaluation and multidisciplinary clinical coordination Photo: Liv Hospital Ulus via FL Comms ISTANBUL, April 02, 2026 (GLOBE NEWSWIRE) -- [...]
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
02/04/2026
Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing regimen allows patients [...]
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
02/04/2026
Celebrating 15 years of impact, the program supports Canadian students with Crohn’s disease or ulcerative colitis with fifteen $5,000 scholarships in 2026 TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Crohn’s and Colitis [...]
Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications
02/04/2026
The discount card platform is disrupting a multi-billion-dollar industry in just four years ESTERO, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Visory Health , a patient-first health tech prescription platform that is [...]
GENFIT : Résultats financiers annuels 2025 et point sur les activités de la Société
02/04/2026
Faits financiers marquants de 2025 : Trésorerie et équivalents de trésorerie s’élevant à 101.1 millions d’euros au 31 décembre 2025 Chiffre d’affaires s’élevant à 65.4 millions d’euros au 31 décembre 2025, dont 43.6 [...]
EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand
02/04/2026
EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand Paris, France and Bangkok, Thailand (2 April 2026) – EssilorLuxottica and Top Charoen today announced that they have closed a [...]
Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026
02/04/2026
Depuis 15 ans, le programme soutient des étudiants canadiens atteints de la maladie de Crohn ou de colite ulcéreuse, en octroyant quinze bourses d'études de 5 000 $ TORONTO, 02 avr. 2026 (GLOBE NEWSWIRE) -- Crohn et [...]
EssilorLuxottica entre au capital de Top Charoen pour renforcer sa présence en Thailande
02/04/2026
EssilorLuxottica entre au capital de Top Charoen pour renforcer sa présence en Thailande Paris, France et Bangkok, Thaïlande (2 avril 2026) – EssilorLuxottica et Top Charoen annoncent aujourd’hui la finalisation d’une [...]
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update
02/04/2026
2025 financial highlights: Cash and cash equivalents totaled €101.1 million as of December 31, 2025 Revenues amounting to €65.4 million for the period ended December 31, 2025, including €43.6 million in milestones and € [...]
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
02/04/2026
SUNNYVALE, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]
Medicana Health Group Marks World Autism Awareness Day with a Call for Inclusion, Earlier Recognition and Family-Centered Support
02/04/2026
Medicana Ataköy Hospital in Istanbul highlights multidisciplinary care, responsible public dialogue and quality-led healthcare standards Photo: Medicana Ataköy Hospital via FL Comms ISTANBUL, April 02, 2026 (GLOBE [...]
Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide
02/04/2026
POMPANO BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced significant reimbursement milestones for its Freedom ® [...]
Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
02/04/2026
If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to progressive, irreversible neurodegeneration and early death [...]
PracticeLink Reveals Evolved Brand Identity Focused on Clarity, Simplicity and Trust for Healthcare Providers and Recruiters
02/04/2026
Updated identity reflects a clearer standard for what clinicians and hiring teams can expect—delivered steadily instead of disruptively ST. LOUIS and HINTON, West Virginia, April 02, 2026 (GLOBE NEWSWIRE) -- [...]
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
02/04/2026
Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k) submission with method comparison, usability, and interference [...]
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
02/04/2026
CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University Irving Medical Center in New York, NY as the newest Qualified [...]
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
02/04/2026
Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals, Inc. (Nasdaq: CURX) (“Curanex” or the “Company [...]

Pages